Atherosclerotic cardiovascular risk assessment in a 24-week, randomized, double-blind, placebo-controlled study of aldafermin

被引：0

作者：

Gunn, Nadege T. ^{[1
]}

Ling, Lei ^{[2
]}

Neff, Guy ^{[3
]}

Guy, Cynthia ^{[4
]}

Bashir, Mustafa ^{[4
]}

Paredes, Angelo ^{[5
]}

Frias, Juan ^{[6
]}

Younes, Ziad H. ^{[7
]}

Trotter, James F. ^{[8
]}

Moussa, Sam ^{[9
]}

Kohli, Anita ^{[10
]}

Connelly, Margery A. ^{[11
]}

Nelson, Kristen ^{[2
]}

Gottwald, Mildred ^{[2
]}

Chang, William ^{[2
]}

Yan, Andrew ^{[2
]}

DePaoli, Alex ^{[2
]}

Lieu, Hsiao ^{[2
]}

Harrison, Stephen ^{[12
]}

机构：

[1] Pinnacle Clin Res, Austin, TX USA

[2] NGM Biopharmaceut, San Francisco, CA USA

[3] Covenant Res & Clin, Ft Myers, FL USA

[4] Duke Univ, Durham, NC 27706 USA

[5] Brooke Army Med Ctr, Ft Sam Houston, TX 78234 USA

[6] Natl Res Inst, Los Angeles, CA USA

[7] Gastro One Res, Germantown, TN USA

[8] Texas Digest Dis Consultants, Dallas, TX USA

[9] Adobe Clin Res, Tucson, AZ USA

[10] Arizona Liver Hlth, Chandler, AZ USA

[11] Labcorp, Morrisville, NC USA

[12] Pinnacle Clin Res, San Antonio, TX USA

来源：

JOURNAL OF HEPATOLOGY | 2021年 / 75卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

PO-1082

引用

页码：S617 / S617

页数：1

共 50 条

[41] Safety and efficacy of paliperidone extendedrelease in Chinese patients with schizophrenia: a 24-week, open-label extension of a randomized, double-blind, placebo-controlled study
Zhang, Hongyan
Li, Huafang
Liu, Yanning
Wu, Cathy
Wu, Qingqi
Nuamah, Isaac
Shi, Jianguo
Xie, Shiping
Wang, Gang
Gopal, Srihari
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 69 - 77
[42] A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of the Rivastigmine Patch in Japanese Patients with Alzheimer's Disease
Nakamura, Yu
Imai, Yukimichi
Shigeta, Masahiro
Graf, Ana
Shirahase, Toru
Kim, Hyosung
Fujii, Akifumi
Mori, Joji
Homma, Akira
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2011, 1 (01): : 163 - 179
[43] Vildagliptin in drug-naive patients with type 2 diabetes: A 24-week, double-blind, randomized, placebo-controlled, multiple-dose study
Dejager, S.
Razac, S.
Foley, J. E.
Schweizer, A.
HORMONE AND METABOLIC RESEARCH, 2007, 39 (03) : 218 - 223
[44] Dapagliflozin Added to Usual Care in Individuals with Type 2 Diabetes Mellitus with Preexisting Cardiovascular Disease: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study with a 28-Week Extension
Leiter, Lawrence A.
Cefalu, William T.
de Bruin, Tjerk W. A.
Gause-Nilsson, Ingrid
Sugg, Jennifer
Parikh, Shamik J.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2014, 62 (07) : 1252 - 1262
[45] Impact of Evolocumab on the Pharmacodynamic Effects of Clopidogrel in Patients With Atherosclerotic Cardiovascular Disease: A Randomized, Double-Blind, Placebo-Controlled Study
Ortega-Paz, Luis
Rollini, Fabiana
Been, Latonya
Rivas, Andrea
Maaliki, Naji
Pineda, Andres
Suryadevara, Siva
Soffer, Daniel
Zenni, Martin
Angiolillo, Dominick
Franchi, Francesco
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (12) : B235 - B235
[46] Empagliflozin as Add-on to Metformin Plus Sulfonylurea in Patients With Type 2 Diabetes A 24-week, randomized, double-blind, placebo-controlled trial
Haering, Hans-Ulrich
Merker, Ludwig
Seewaldt-Becker, Elke
Weimer, Marc
Meinicke, Thomas
Woerle, Hans J.
Broedl, Uli C.
DIABETES CARE, 2013, 36 (11) : 3396 - 3404
[47] Effect of inorganic nitrate on metabolic parameters in patients with type 2 diabetes: A 24-week randomized double-blind placebo-controlled clinical trial
Bahadoran, Zahra
Norouzirad, Reza
Mirmiran, Parvin
Gaeini, Zahra
Jeddi, Sajad
Shokri, Majid
Azizi, Fereidoun
Ghasemi, Asghar
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2021, 107 : 58 - 65
[48] Scalp application of antioxidants improves scalp condition and reduces hair shedding in a 24-week randomized, double-blind, placebo-controlled clinical trial
Davis, Michael G.
Piliang, Melissa P.
Bergfeld, Wilma F.
Caterino, Tamara L.
Fisher, Brian K.
Sacha, Jarek P.
Carr, Gregory J.
Moulton, Laura T.
Whittenbarger, Deborah J.
Schwartz, James R.
INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, 2021, 43 : S14 - S25
[49] Escitalopram Treatment for Depressive Disorder Following Acute Coronary Syndrome: A 24-Week Double-Blind, Placebo-Controlled Trial
Kim, Jae-Min
Bae, Kyung-Yeol
Stewart, Robert
Jung, Bo-Ok
Kang, Hee-Ju
Kim, Sung-Wan
Shin, Il-Seon
Hong, Young Joon
Kim, Ju Han
Shin, Hee-Young
Kang, Gaeun
Ahn, Youngkeun
Kim, Jong-Keun
Jeong, Myung Ho
Yoon, Jin-Sang
JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (01) : 62 - U138
[50] Muraglitazar, a dual (α/γ) PPAR activator:: A randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes
Buse, JB
Rubin, CJ
Frederich, R
Viraswami-Appanna, K
Lin, KC
Montoro, R
Shockey, G
Davidson, JA
CLINICAL THERAPEUTICS, 2005, 27 (08) : 1181 - 1195

← 1 2 3 4 5 →